Brief: Larimar Therapeutics Q1 Net Income USD -29.613 Million
May 14 (Reuters) - Larimar Therapeutics Q1 income from operations USD -31.117 million. Q1 operating expenses USD 31.117 million Q1 EPS USD -0.31
Recent news on Larimar Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Regenxbio, Repay, Natera, Fortune Brands
Larimar tumbles as safety concerns resurface in rare disease drug study update
U.S. STOCKS ON THE MOVE-Regenxbio, Repay, Natera, Fortune Brands
U.S. STOCKS ON THE MOVE-SpaceX, Charter, Gulfport Energy
Larimar tumbles as safety concerns resurface in rare disease drug study update